Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023	Mar. 31, 2023
Current assets:
Cash and cash equivalents	$ 45,753	$ 38,241
Restricted cash	205,645	256,237
Derivatives	29,327	17,958
Prepaid expenses and other current assets	3,193	2,089
Total current assets	283,918	314,525
Property, plant and equipment, net	3,158,242	2,437,733
Operating lease right-of-use assets	169,504	170,827
Debt issuance costs	371,466	389,695
Derivatives	175,699	0
Other non-current assets	17,054	11,021
Total assets	4,175,883	3,323,801
Current liabilities:
Accounts payable	175,384	243,129
Accrued and other current liabilities	321,997	299,264
Common stock warrants	5,297	6,851
Operating leases	2,972	3,143
Total current liabilities	505,650	552,387
Common stock warrants	0	1,818
Operating leases	145,466	145,962
Derivative liability	0	66,899
Debt, net	2,393,730	1,816,301
Total liabilities	3,044,846	2,583,367
Commitments and contingencies (Note 12)
Stockholders’ equity
Common stock, $0.0001 par value, 480.0 million authorized: 257.5 million and 256.5 million outstanding, respectively	26	26
Treasury stock: 2.2 million shares and 2.2 million respectively, at cost	(14,308)	(14,214)
Preferred stock, $0.0001 par value, 0.5 million authorized after designation of the convertible preferred stock: none outstanding	0	0
Additional paid-in-capital	897,805	693,883
Accumulated deficit	(363,426)	(391,772)
Total stockholders’ equity	520,097	287,923	$ 56,836
Non-controlling interest	610,940	452,511
Total equity	1,131,037	740,434	$ 54,371
Total liabilities and equity	$ 4,175,883	$ 3,323,801